多糖:神经病变的来源,相关机制和治疗潜力
Zeeshan Ali1, Nishat Fatma2, Phool Chandra3
1Sahara Degree College, Rampur-244901, Uttar Pradesh, India.
Central nervous system agents in medicinal chemistry
|September 22, 2025
概括
多糖类是具有抗氧化和抗炎性能的天然化合物,在治疗神经病变方面表现有前途. 需要进一步的研究来确认它们在神经再生和修复方面的治疗潜力.
科学领域:
- 生物化学 生物化学
- 神经科学是一个神经科学.
- 药理学 药理学是指药理学的学科.
背景情况:
- 神经病变涉及外围神经损伤,导致疼痛,麻木和软弱.
- 糖尿病,自身免疫性疾病,感染和化疗都可能导致神经病变.
- 多糖是来自自然来源的复杂碳水化合物,具有多样化的生物活动.
研究的目的:
- 审查多糖的自然来源.
- 探索它们在神经病变中的作用机制.
- 评估它们在神经保护和神经病症管理方面的治疗潜力.
主要方法:
- 关于多糖和神经病变的研究的文献综述.
- 分析生物活动,包括抗氧化,抗炎和神经保护作用.
- 研究神经再生和修复中的多糖机制.
主要成果:
- 多糖具有显著的抗氧化特性,保护神经元免受氧化应激.
- 它们具有抗炎,抗菌和抗癌活性.
- 研究表明神经再生,修复和神经保护的潜力.
结论:
- 多糖是神经病变管理的有前途的治疗药物.
- 它们的抗氧化和抗炎性质是它们神经保护作用的关键.
- 需要进一步的临床验证和机制研究.
相关概念视频
Biosynthesis of Polysaccharides
559
Polysaccharides such as glycogen and starch are synthesized from nucleoside diphosphate sugars, primarily uridine diphosphate glucose (UDPG) and adenosine diphosphate glucose (ADPG). These activated glucose donors act as key intermediates in carbohydrate metabolism and biosynthesis. UDPG primarily involves glycogen synthesis in animals and many bacteria, while ADPG plays a fundamental role in starch synthesis in plants and certain bacteria.UDPG is formed when glucose-1-phosphate reacts with...
559
Glucagon-like Receptor Agonists
850
Incretins include glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP), which stimulate insulin secretion post-meals. In type 2 diabetes, GIP's efficacy is reduced, making GLP-1 a viable drug target. GIP originates from preproGIP.
GLP-1, when administered in high doses intravenously, triggers insulin secretion, inhibits glucagon release, slows gastric emptying, reduces food intake, and restores normal insulin secretion. However, its rapid inactivation by...
GLP-1, when administered in high doses intravenously, triggers insulin secretion, inhibits glucagon release, slows gastric emptying, reduces food intake, and restores normal insulin secretion. However, its rapid inactivation by...
850
Proteoglycans
4.7K
Glycans, a class of complex heterogeneous molecules, can be covalently attached to proteins to form glycosylated proteins that regulate various physiological and pathological processes. Glycosylated proteins or glycoproteins comprise N-linked and O-linked oligosaccharides. O-glycosylation is the most common type of protein glycosylation. Here, glycans attach to the oxygen atom of the hydroxyl groups of Serine or Threonine residues. O-linked glycosylation occurs later in protein processing,...
4.7K
Oral Hypoglycemic Agents: α-Glucosidase Inhibitors
526
α-glucosidase inhibitors, including acarbose (Precose), miglitol (Glyset), and voglibose (Voglib) (primarily available in Asia), are drugs that control blood sugar levels by delaying the digestion of starch and disaccharides. They achieve this by inhibiting α-glucosidase enzymes in the intestine, which slow the absorption of carbohydrates in the intestine, which in turn leads to a prolonged release of the glucoregulatory hormone GLP-1 from intestinal L-cells.
Acarbose and miglitol are...
Acarbose and miglitol are...
526
Oligosaccharide Assembly
3.5K
Protein glycosylation starts in the ER lumen and continues in the Golgi apparatus. Glycosyltransferases catalyze the addition of sugar molecules or glycosylation of proteins. Usually, these enzymes add sugars to the hydroxyl groups of selected serine or threonine residues to form O-linked glycans or the amino groups of asparagine residues to form N-linked glycans. Different positions on the same polypeptide chain can contain differently linked glycans.
Multiple sugar molecules that may or may...
Multiple sugar molecules that may or may...
3.5K
Analgesia and Pain Management
1.5K
Pain is critical to various clinical pathologies, provoking an urgent need for effective management. Pain, whether acute or chronic, is a complex neurochemical process. Its alleviation depends on the type, with nonopioid analgesics effective for mild to moderate pain, such as musculoskeletal or inflammatory pain, while neuropathic pain responds best to anticonvulsants, tricyclic antidepressants, or serotonin/norepinephrine reuptake inhibitors. For severe acute or chronic pain, opioids may be...
1.5K


